| Detected | Trial | Change |
|---|---|---|
| 2026-06-06 | NCT04074096 Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma… |
date change Primary completion pushed: 2026-03-27 -> 2026-05-07 |
| 2026-06-06 | NCT04074096 Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma… |
date change Completion pushed: 2026-03-27 -> 2027-03-27 |
| 2026-05-27 | NCT07237256 Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated… |
Trial sites expanded: 110 -> 138 locations |
| 2026-05-20 | NCT07359456 Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic… |
date change Primary completion pushed: 2028-03 -> 2029-08 |
| 2026-05-20 | NCT07359456 Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic… |
date change Completion pushed: 2032-03 -> 2033-08 |
| 2026-05-20 | NCT03643133 Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk… |
date change Primary completion pushed: 2026-01 -> 2026-09 |
| 2026-05-20 | NCT07237256 Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated… |
Trial sites expanded: 70 -> 110 locations |
| 2026-05-20 | NCT07340619 Clinical Trial Evaluating the Biological Activity of a New Drug Identified as… |
Trial sites expanded: 0 -> 8 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT04916613 | ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable… | Prostate Cancer Metastatic | Recruiting |
| NCT05615818 | Personalized Medicine for Advanced Biliary Cancer Patients | Biliary Tract Neoplasms | Recruiting |
| NCT07237256 | Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated… | Breast Cancer | Recruiting |
| NCT07340567 | Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal… | Colorectal Cancer | Not Yet Recruiting |
| NCT03774732 | PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in… | Non Small Cell Lung Cancer | Active, Not Recruiting |
| NCT07106632 | Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent… | Early Breast Cancer | Not Yet Recruiting |
| NCT01376752 | Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment | Ovarian Epithelial Cancer Recurrent | Active, Not Recruiting |
| NCT07284394 | Liver-directed Chemotherapy After Surgery of Liver Metastases of Colorectal Cancer in… | Colorectal Adenocarcinoma Metastatic in the Liver | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT06904170 | Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in… | Hepatocellular Carcinoma | Recruiting |
| NCT07437287 | Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant… | Biliary Tract Cancer (BTC) | Not Yet Recruiting |
| Phase 2 | |||
| NCT07262489 | Neo-adjuvant Immunotherapy Master Trial for Localized Cancers | Localized Cancer | Recruiting |
| NCT07230613 | Neo-adjuvant Immunotherapy in Patients With Localized Melanoma | Cutaneous Melanoma, Stage III | Recruiting |
| NCT06475352 | Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking… | Digestive Cancer | Recruiting |
| NCT06846346 | Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic… | Metastatic Esophageal Adenocarcinoma | Recruiting |
| NCT06529718 | Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients | Biliary Tract Cancer | Recruiting |
| NCT07360743 | Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1… | Non Small Cell Lung Cancer (Squamous or Non Squamous) | Not Yet Recruiting |
| NCT07431073 | Immunotherapy Master Trial for Advanced Cancers | Advanced / Metastatic Solid Tumors | Not Yet Recruiting |
| NCT05617963 | Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer… | Small Cell Lung Carcinoma | Active, Not Recruiting |
| NCT03643133 | Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk… | Osteosarcoma | Active, Not Recruiting |
| NCT07340619 | Clinical Trial Evaluating the Biological Activity of a New Drug Identified as… | Metastatic (Stage IV) Melanoma | Not Yet Recruiting |
| NCT07359456 | Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic… | Metastatic Colorectal Cancer | Not Yet Recruiting |
| NCT04074096 | Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma… | Malignant Melanoma | Active, Not Recruiting |
| Not specified | |||
| NCT07120087 | Evaluation of an Online Intervention to Educate Women at High Risk of Breast Cancer on… | Breast Cancer | Recruiting |
| NCT07187726 | Arm Swelling Occurence in Breast Cancer Patients With Nodal Radiotherapy: Impact of… | Unilateral Breast Neoplasms | Recruiting |
| NCT03275311 | Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008 | Metastatic Breast Cancer | Recruiting |